THIS TITLE Title 21-FOOD AND DRUGS is composed of nine volumes. The parts in volumes are arranged in the following order: Parts 1-99, 100-169, 170-199, 299, 300-499, 500-599, 600-799, 800-1299 and 1300-End. The first eight volu containing Parts 1-1299, comprise Chapter I-Food and Drug Administra Department of Health and Human Services. The ninth volume, containing 1300 to End, includes Chapter II-Drug Enforcement Administration, De ment of Justice. The contents of these volumes represent all current regula codified under this title of the CFR as of April 1, 1989. The Table of Excepted Prescription Drugs to Part 1308 appears in the vol containing Part 1300-End. Redesignation tables for Chapter I-Food and Drug Administration appea the Finding Aids section of the first eight volumes. For this volume, Ina C. Masters was Chief Editor. The Code of Federal R lations publication program is under the direction of Richard L. Claypoole sisted by Ruth C. Pontius. CHAPTER I-FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (Parts 1 to 99) EDITORIAL NOTES: 1. Nomenclature changes affecting this chapter appear at 45 F June 17, 1980, and 46 FR 8454, Jan. 27, 1981. 2. Food and Drug Administration published a document at 49 FR 41019, Oct. 19, tablishing July 1, 1987, as a uniform effective date for compliance for regulations the labeling of food products. At 51 FR 34085, Sept. 25, 1986, FDA established Ja 1989 as a new uniform effective date for compliance. The new uniform effective apply only to final FDA food labeling regulations published after July 1, 1986, an January 1, 1988. Part 1 257 SUBCHAPTER A-GENERAL General regulations for the enforcement of the General administrative rulings and decisions. Administrative practices and procedures....... Regulatory hearing before the Food and Drug Ad Standards of conduct and conflicts of interest Public information Protection of privacy Environmental impact considerations..... Protection of human subjects........... Institutional Review Boards......... Good laboratory practice for nonclinical laborato ry studies............................... 10 12 13 14 15 16 19 20 21 25 50 56 58 60 |